Avanos Medical CEO and leadership

Accomplished Senior Financial Executive with experience in diverse industries, both public and private, as well as private-equity backed organizations. Combined industry and public accounting background. Broad-based financial experience includes P&L management, financial planning and analysis, business analytics, treasury and tax planning and operations, and board level communications and reporting. Experienced at executing strategic growth plans, both organically and via acquisitions. Have had responsibility for all Finance and controllership operations, as well as Corporate Real Estate, Human Resources and Payroll.

Core Financial and Executive Skills: Board of Directors and Audit Committee interaction, Banking and Investor Relationships, Corporate Finance, Tax Planning and Strategies, Budget Preperation and Financial Analysis, Treasury Operations, Controllership, US GAAP and International Technical Accounting, SEC Reporting, Financial Systems, Mergers and Acquisitions, including Structuring, Due Diligence and Integration.

Industries: Medical Devices, Pharmaceutical and Biotech; Online Media and Advertising Technology; Computer Integrated Manufacturing; Consumer and Industrial Products

As Senior Vice President, Chief Ethics and Compliance Officer, Michelle Scharfenberg oversees all aspects of the global Ethics & Compliance Program.

Michelle joined the company in 2020, bringing over 20 years of experience in providing legal advice to business teams, building compliance programs, and integrating compliance into business operations and culture.

Prior to joining Avanos, Michelle served as Vice President and Chief Compliance Officer of Cantel Corporation, a leading provider of infection prevention products and services in the healthcare and dental markets. She also held roles of increasing responsibility in the legal and compliance departments at Integra LifeSciences Corporation, including Chief Compliance Officer and General Counsel for Global Operations.

She holds a bachelor’s degree from Ursinus College in English, and a juris doctor from The Dickinson School of Law of the Pennsylvania State University.

Michelle has been an active member of the Advanced Medical Technology Association (AdvaMed) Device and Diagnostic Compliance Group for over 10 years.

Accomplished Senior Financial Executive with experience in diverse industries, both public and private, as well as private-equity backed organizations. Combined industry and public accounting background. Broad-based financial experience includes P&L management, financial planning and analysis, business analytics, treasury and tax planning and operations, and board level communications and reporting. Experienced at executing strategic growth plans, both organically and via acquisitions. Have had responsibility for all Finance and controllership operations, as well as Corporate Real Estate, Human Resources and Payroll.

Core Financial and Executive Skills: Board of Directors and Audit Committee interaction, Banking and Investor Relationships, Corporate Finance, Tax Planning and Strategies, Budget Preperation and Financial Analysis, Treasury Operations, Controllership, US GAAP and International Technical Accounting, SEC Reporting, Financial Systems, Mergers and Acquisitions, including Structuring, Due Diligence and Integration.

Industries: Medical Devices, Pharmaceutical and Biotech; Online Media and Advertising Technology; Computer Integrated Manufacturing; Consumer and Industrial Products